COR: Cencora, Inc.
About
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Current Value
$240.951 Year Return
Current Value
$240.951 Year Return
Key Details
Market Cap
$47.48B
P/E Ratio
32.09
1Y Stock Return
21.20%
1Y Revenue Growth
12.12%
Dividend Yield
0.91%
Price to Book
51.3
Strategies that include COR
Stock's related to COR
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | 59.35% | $78.15B | +35.51% | 0.42% |
| CAH | 54.42% | $28.64B | +12.14% | 1.70% |
| MA | 37.02% | $476.78B | +27.02% | 0.51% |
| SYK | 34.40% | $148.17B | +32.36% | 0.82% |
| RSG | 34.09% | $66.05B | +31.79% | 1.04% |
| SLGN | 32.48% | $5.80B | +30.44% | 1.38% |
| SYY | 30.99% | $36.55B | +4.35% | 2.73% |
| ABBV | 29.75% | $294.35B | +20.07% | 3.72% |
| CHD | 28.34% | $27.18B | +19.50% | 1.03% |
| RNR | 28.27% | $13.74B | +23.09% | 0.58% |
| TMUS | 27.28% | $270.63B | +56.92% | 0.83% |
| KHC | 26.98% | $36.98B | -10.45% | 5.23% |
| ELV | 26.28% | $91.42B | -16.23% | 1.61% |
| ASH | 25.77% | $3.73B | -1.96% | 2.08% |
| LMT | 25.73% | $126.40B | +18.99% | 2.36% |
| CLX | 25.16% | $20.81B | +20.66% | 2.88% |
| OMI | 24.46% | $956.92M | -33.32% | 0.00% |
| V | 24.02% | $595.29B | +23.64% | 0.69% |
| PG | 23.99% | $402.15B | +14.14% | 2.33% |
| ABT | 23.62% | $203.16B | +14.93% | 1.88% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ESNT | <0.01% | $5.93B | +16.81% | 1.96% |
| ARIS | -0.01% | $763.08M | +214.02% | 1.56% |
| GRWG | 0.01% | $103.68M | -30.00% | 0.00% |
| MORN | 0.01% | $14.36B | +21.83% | 0.49% |
| FTNT | -0.01% | $69.59B | +72.67% | 0.00% |
| ACI | 0.02% | $11.16B | -9.32% | 2.50% |
| IRS | -0.03% | $1.22B | +117.95% | 4.11% |
| CHH | -0.03% | $6.84B | +27.72% | 0.79% |
| LPTX | 0.03% | $103.46M | +10.66% | 0.00% |
| GMAB | -0.04% | $13.02B | -33.87% | 0.00% |
| BLK | -0.04% | $159.23B | +41.88% | 1.96% |
| RXO | -0.05% | $4.41B | +36.42% | 0.00% |
| TMHC | -0.05% | $7.19B | +55.90% | 0.00% |
| CMI | -0.06% | $49.64B | +61.69% | 1.90% |
| CHTR | 0.06% | $54.72B | -4.38% | 0.00% |
| BK | -0.06% | $56.43B | +65.37% | 2.29% |
| AMLX | 0.06% | $357.82M | -58.70% | 0.00% |
| IART | 0.07% | $1.77B | -40.82% | 0.00% |
| AHCO | 0.07% | $1.31B | +17.07% | 0.00% |
| TKC | -0.08% | $5.80B | +35.51% | 1.30% |
ETF's related to COR
News
MarketWatch
Cencora Inc. stock underperforms Tuesday when compared to competitors
SeekingAlpha
November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.
MarketWatch
Cencora Inc. stock outperforms competitors on strong trading day
SeekingAlpha
Walgreens Boots Alliance's 11.9% dividend yield is not covered by free cash flow. Read what makes WBA stock a risky investment.
SeekingAlpha
I expect 10 companies to announce their annual increases in the second half of November. Click here for a detailed analysis.
MarketWatch
Cencora Inc. stock outperforms competitors despite losses on the day
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.